Records containing: Obesity
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2026-04-20A Single-ascending and Multiple-ascending Dose Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension and Participants With Decreased Estimated Glomerular Filtration Rate
-
CLINICAL_TRIALS study record update · 2026-04-20Treatment With Tirzepatide of the Disease of Obesity in People With Type 1 Diabetes
-
CLINICAL_TRIALS study record update · 2026-04-20Influence of a Different Percentage of Nutrients on the Effects of a Low-calorie Mediterranean Diet Associated With Physical Exercise on the Parameters of Steatosis, Intestinal Function and Metabolic Risk in Patients With Obesity and NAFLD
-
CLINICAL_TRIALS study record update · 2026-04-20Cardiovascular Health and Needs Assessment in Washington D.C. - Development of a Community-Based Behavioral Weight Loss Intervention
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 2b, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of KAI-9531 Administered Once Weekly in Participants Living With Obesity Who Do Not Have Diabetes
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2026-04-20The Thetis Study: A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy of Tradipitant on Nausea and Vomiting After GLP-1R Agonist Administration in Healthy Overweight or Obese Volunteers
-
CLINICAL_TRIALS study record update · 2026-04-20Efficacy and Safety of Tirzepatide Once Weekly Versus Placebo for the Treatment of Obesity and Weight-Related Comorbidities in Adolescents: A Randomized, Double-Blind, Placebo- Controlled Trial (SURMOUNT-ADOLESCENTS-2)
-
CLINICAL_TRIALS study record update · 2026-04-20Assessment of Thirst and Role of Water/Electrolytes Homeostasis During Water Deprivation in Obesity
-
CLINICAL_TRIALS study record update · 2026-04-20A Master Protocol to Investigate the Efficacy and Safety of Orforglipron Tablet Once Daily Compared With Placebo in Participants With Obesity or Overweight With and Without Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2026-04-20A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, Without Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2026-04-17The Impact of Pramlintide on Top of Semaglutide in Obese People With Prediabetes
-
CLINICAL_TRIALS study record update · 2026-04-17Impact of Gastroenteroanastomosis Simultaneous to Vertical Gastrectomy on Post-operative Gastroesophageal Reflux
-
CLINICAL_TRIALS study record update · 2026-04-17A Single-Dose and Multiple-Ascending Dose Study of LY4086940 in Healthy Participants and Participants With Overweight or Obesity, With or Without Type 2 Diabetes
-
CLINICAL_TRIALS study record update · 2026-04-17Evaluation of Endoscopic Sleeve Gastroplasty (ESG) as an Alternative Weight Loss Strategy for Patients With Obesity Discontinuing GLP-1 Receptor Agonists Due to Intolerance or Ineffectiveness: A Retrospective Study
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 4 Multicenter, Randomized, Open-Label, Interventional Study With Pragmatic Elements Investigating the Effectiveness of Tirzepatide Once Weekly Compared With Standard of Care in Adult Participants With Obesity and Without Diabetes in a Real-World Setting
-
CLINICAL_TRIALS study record update · 2026-04-17Outcome of Body Composition Assessment in Patients With Severe Obesity Undergoing Metabolic Surgery
-
CLINICAL_TRIALS study record update · 2026-04-17Collection of Human Tissue Samples From the Neck Region for Characterization of Its Molecular and Biochemical Signatures
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 3, Open-Label Study of Once Daily LY3502970 Compared With Insulin Glargine in Adult Participants With Type 2 Diabetes and Obesity or Overweight at Increased Cardiovascular Risk
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 3, Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Retatrutide Once Weekly in Participants Who Have Obesity or Overweight and Chronic Low Back Pain
-
CLINICAL_TRIALS study record update · 2026-04-17The Effect of Oral SPM Supplementation on INflammation-induced Vascular Ageing in Obese Hypertensive Patients
-
CLINICAL_TRIALS study record update · 2026-04-17Bone Metabolism in Adolescents Undergoing GLP-1 Receptor Agonist Therapy
-
CLINICAL_TRIALS study record update · 2026-04-17Bioequivalence of Survodutide (BI 456906) When Administered Via Pre-filled Syringe (Formulation A) and Pre Filled Pen (Formulation B2) in Male and Female Trial Participants Who Are Healthy or Otherwise Healthy With Overweight/Obesity (an Open-label, Randomised, Single-dose, Two-period, Two-sequence Crossover Trial)
-
CLINICAL_TRIALS study record update · 2026-04-17A Randomized, Double-Blind, Placebo-Controlled, Parallel Group, Multi-Center Phase 2 Study to Evaluate the Efficacy, Safety, and Tolerability of Once-Weekly CT-388 Administered for 48 Weeks to Participants With Obesity or Overweight With at Least One Weight-Related Comorbidity
-
CLINICAL_TRIALS study record update · 2026-04-17A Randomized, Placebo-Controlled Clinical Trial of Once Daily Oral Cannabis for Weight Loss in Obese Individuals
-
CLINICAL_TRIALS study record update · 2026-04-17A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study to Investigate the Efficacy and Safety of Once Weekly Eloralintide in Adult Participants With Obesity or Overweight, and Type 2 Diabetes